A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
|ClinicalTrials.gov Identifier: NCT00044135|
Recruitment Status : Unknown
Verified November 2002 by Triangle Pharmaceuticals.
Recruitment status was: Active, not recruiting
First Posted : August 21, 2002
Last Update Posted : June 24, 2005
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||No date given|
|Study Completion Date :||No date given|